Canadian Generic Pharmaceutical Association ads

Keep up to date on Canada's generic pharmaceutical industry.

Congratulations to CGPA member company, Marcan Pharmaceuticals. Earlier this week, members of the CGPA leadership team, including President Jim Keon, Vice President of Federal and International Affairs Jody Cox, and Kristin Willemsen, Vice President of Scientific and Regulatory Affairs, had the pleasure of attending Marcan's 20th anniversary celebration. Thank you to the team at Marcan Pharmaceuticals Inc. for including us in your big day and inviting Jim to speak at the celebration. And congratulations on two decades of contributing to the affordable, sustainable and homegrown healthcare that Canadian generics provide. Atul Aggarwal Sudheer Paladugu Mark Sutcliffe Emcure Pharmaceuticals Limited Mantra Pharma

In a new op-ed for National Newswatch, Jim Keon, the president of CGPA and its Biosimilars Canada | Biosimilaires Canada division, calls on the federal government to invest in Health Canada's drug review capacity to accelerate access to cost-saving generics and biosimilars. As Jim’s piece notes, right now over 500 generic drug submissions are under review, and more than 100 are backlogged. These delays increase costs for public and private drug plans, employers and patients, and prevent the savings that generic and biosimilar medicines are designed to deliver. "Each day of delayed drug competition can result in millions of dollars in extra costs," Jim writes. And those are costs Canadians shouldn't have to pay. It's time to prioritize timely access to affordable medicines. Read the full op-ed: Https://https://lnkd.in/eAk2G5Dr #cdnpoli #Budget2025

The CGPA and its member companies would like to thank The Hon. Victor Fedeli, Ontario’s Minister of Economic Development, Job Creation and Trade, along with The Hon. Nina Tangri, and MPPs John Jordan, Frances Gélinas, and Lee Fairclough for meeting with us at Queen’s Park yesterday. We value the opportunity to continue our dialogue with the government about the importance of generic pharmaceuticals for Ontario. Not only do generics make the province’s health-care system more affordable, they also support the province’s life science sector, provide manufacturing jobs, and increase exports. In our conversations, we highlighted the importance of timely approvals for generics and biosimilars as well as the need for additional Health Canada resources to help meet the growing demand for affordable medicines. We look forward to continuing these important conversations to benefit patients, the health-care system, and Ontario’s economy.

The federal budget tabled on November 4 includes important measures to support domestic life sciences and manufacturing investments. Budget 2025 did not provide the resources Health Canada urgently needs to address its growing backlog of generic and biosimilar drug submissions. Drug reviews are cost-recovered, with industry covering 75 per cent of the cost. Drug reviews are a core Health Canada regulatory program and require increased and sustained resources to return to predictable operations and eliminate the backlog. The CGPA and its member companies remain committed to working collaboratively with the federal government and Health Canada to restore timely drug review processes, and ensure Canadians have access to affordable, quality-assured medicines. Read our full statement here: https://lnkd.in/eBkVGPG4 #cdnpoli #Budget2025 Health Canada | Santé Canada

The CGPA welcomes the decision by Quebec’s Ministry of Health and Social Services to increase the number of formulary updates to the lists of medications from 9 to 12 per year starting in 2026. This decision reflects Minister Christian Dubé’s clear commitment to accelerating patient access to generic medications. This measure, which is essential to Quebec’s healthcare system, will help speed up the market entry of generic medicines and could generate annual savings of up to $5 million. We are pleased that this initiative reflects our 2025-2026 pre-budget recommendations submitted to the Minister of Finance, which can be viewed here:https://lnkd.in/eXR4imBV A big thank you to the Government of Quebec for its leadership and commitment in improving access to essential medicines to better meet the needs of patients across the province.